The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2025

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1794134

No of Pages : 91

Synopsis
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market research.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 139%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Nissan Chemical
HIKAL Ltd.
HuBei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu Group
Zhejiang Gihi Chemicals
Taizhou Crene Biotechnology
Segment by Type
Purity ≥98%
Purity <98%
Segment by Application
Oral Drug
External Drug
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index
1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Overview
1.1 Product Definition
1.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Segment by Type
1.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity ≥98%
1.2.3 Purity <98%
1.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Segment by Application
1.3.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Oral Drug
1.3.3 External Drug
1.4 Global Market Growth Prospects
1.4.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Estimates and Forecasts (2018-2029)
1.4.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Manufacturers (2018-2023)
2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Product Offered and Application
2.8 Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Date of Enter into This Industry
2.9 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Competitive Situation and Trends
2.9.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Concentration Rate
2.9.2 Global 5 and 10 Largest Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region
3.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Region (2018-2029)
3.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Region (2024-2029)
3.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region (2018-2029)
3.4.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Region (2024-2029)
3.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Price Analysis by Region (2018-2023)
3.6 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production and Value, Year-over-Year Growth
3.6.1 North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2018-2029)
4 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region
4.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2018-2029)
4.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2018-2023)
4.2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Type (2018-2029)
5.1.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Type (2018-2023)
5.1.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Type (2024-2029)
5.1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Type (2018-2029)
5.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Type (2018-2029)
5.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Type (2018-2023)
5.2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Type (2024-2029)
5.2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Type (2018-2029)
5.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Type (2018-2029)
6 Segment by Application
6.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Application (2018-2029)
6.1.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Application (2018-2023)
6.1.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Application (2024-2029)
6.1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Application (2018-2029)
6.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Application (2018-2029)
6.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Application (2018-2023)
6.2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Application (2024-2029)
6.2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Application (2018-2029)
6.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Nissan Chemical
7.1.1 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.1.2 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.1.3 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Nissan Chemical Main Business and Markets Served
7.1.5 Nissan Chemical Recent Developments/Updates
7.2 HIKAL Ltd.
7.2.1 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.2.2 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.2.3 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.2.4 HIKAL Ltd. Main Business and Markets Served
7.2.5 HIKAL Ltd. Recent Developments/Updates
7.3 HuBei Masteam Bio-tech
7.3.1 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.3.2 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.3.3 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.3.4 HuBei Masteam Bio-tech Main Business and Markets Served
7.3.5 HuBei Masteam Bio-tech Recent Developments/Updates
7.4 Jiangsu Rivocean
7.4.1 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.4.2 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.4.3 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Jiangsu Rivocean Main Business and Markets Served
7.4.5 Jiangsu Rivocean Recent Developments/Updates
7.5 Shaanxi Dideu Group
7.5.1 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.5.2 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.5.3 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Shaanxi Dideu Group Main Business and Markets Served
7.5.5 Shaanxi Dideu Group Recent Developments/Updates
7.6 Zhejiang Gihi Chemicals
7.6.1 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.6.2 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.6.3 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Zhejiang Gihi Chemicals Main Business and Markets Served
7.6.5 Zhejiang Gihi Chemicals Recent Developments/Updates
7.7 Taizhou Crene Biotechnology
7.7.1 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Corporation Information
7.7.2 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.7.3 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Taizhou Crene Biotechnology Main Business and Markets Served
7.7.5 Taizhou Crene Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Chain Analysis
8.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Mode & Process
8.4 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Marketing
8.4.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Channels
8.4.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors
8.5 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Customers
9 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Dynamics
9.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Trends
9.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Drivers
9.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Challenges
9.4 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’